United Therapeutics: Don't Fear The Patent Expiration Too Much
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
Korea Investment CORP Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares ...
Commonwealth Equity Services LLC Acquires 301 Shares of United Therapeutics Co. (NASDAQ:UTHR)
Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during ...
20 Most Expensive Stocks Insiders Are Dumping In March
After being in the green for a few trading sessions, the broader market index slid 0.8% on Wednesday, and blue-chip companies ...
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
FDA sets PDUFA goal date of May 24, 2025MORRISVILLE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for ...
The Manila Times5d
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
Following the presentations, each poster will be available on the Publications page of Liquidia's website at https://liquidia.com/publications.
Insider Monkey4d
Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?
Its products include treatments for pulmonary arterial hypertension (PAH), such as Tyvaso, Remodulin, and Orenitram, as well as a monoclonal antibody for high-risk neuroblastoma called Unituxin.